News & Updates
Filter by Specialty:
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
byAudrey Abella
In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022Fewer hospitalizations with omicron vs delta suggest reduced severity of omicron variant
23 May 2022
byRoshini Claire Anthony
Infection with the omicron variant of SARS-CoV-2 was less likely to result in hospitalization than infection with the delta variant, according to an observational study from Denmark presented at ECCMID 2022 and published in The Lancet.